Susquehanna International Group, LLP Eq Rx, Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.31 $135,622 - $188,727	81,700 New	81,700 $181,000
Q1 2023 May 16, 2023	SELL	$1.8 - $2.83 $360 - $566	-200 Reduced 0.8%	24,800 $48,000
Q4 2022 Feb 14, 2023	SELL	$2.05 - $5.5 $108,034 - $289,850	-52,700 Reduced 67.82%	25,000 $61,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $35,156 - $224,026	37,400 Added 92.8%	77,700 $385,000
Q2 2022 Aug 15, 2022	SELL	$3.2 - $5.69 $336,640 - $598,588	-105,200 Reduced 72.3%	40,300 $189,000
Q1 2022 May 16, 2022	BUY	$2.8 - $7.39 $407,400 - $1.08 Million	145,500 New	145,500 $601,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.